Organiser
The Bradykinin Symposium 2024 and the Angioedema School 2024 will be organized by the Global Allergy and Asthma Excellence Network (GA²LEN):
GA²LEN – The Global Allergy and Asthma Excellence Network is a consortium of leading research centres specialized in allergic diseases, which include asthma. Funded by the European Union under the 6th framework programme, GA²LEN addresses the growing public health concern of allergic diseases.
ACARE – The ACARE program is a joint initiative by GA²LEN (Global Allergy and Asthma Excellence Network) and HAEi (Hereditary Angioedema International) with the aim of developing and accrediting an interactive network of centers of reference and excellence in angioedema management.
Collaboration Partners
UNEV – The urticaria network is an association of people who share the goal of promoting research on the clinical picture for urticaria, and for improving the level of care for patients with urticaria. UNEV promotes projects, campaigns, and research proposals to research into the causes and treatment of urticaria, or inform urticaria patients about their illness.
Frey-Werle Foundation – The purpose of the E.K. Frey – E. Werle Foundation of the Henning L. Voigt Family is the promotion of science and research in the fields of cardiology, hemostaseology and metabolism, in particular to clarify the role of the kallikrein-kinin system and related subjects in health and disease.
European Centre for Allergy Research Foundation (ECARF, founded in 2003) supports nationwide structured research in the field of allergies, the dissemination of the highest quality and knowledge for physicians and the general public as well as initiatives to improve medical care of allergic diseases. Moreover ECARF supports activities to improve the quality of life for people suffering from allergies.
The International Center for Angioedema Research (icare) was founded in 2011 at the Department of Dermatology at the Charité with the aim of improving treatment in the long term for angioedema patients. The center would like all patients to receive the best possible diagnosis and treatment, and offer extensive advice in all aspects, in order to continue achieving significant improvements for these patients.
